Data from The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative Chemotherapy
Adrienne G. Waks(Harvard University), Sara M. Tolaney(Harvard University), Evisa Gjini(Brigham and Women's Hospital), Heather Ann Brauer(Gates Foundation), Zaibo Li(The Ohio State University Wexner Medical Center), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Robert Wesolowski(The Ohio State University Wexner Medical Center), Ian E. Krop(Yale Cancer Center), William T. Barry, Christina Hartl(Io Therapeutics (United States)), Daniel G. Stover(Harvard University), Scott J. Rodig(Brigham and Women's Hospital), Charles M. Perou(University of North Carolina at Chapel Hill), Deborah Dillon(Harvard University), Eric P. Winer(University of Vermont), Amy Sullivan, Mikel Lipschitz(Brigham and Women's Hospital), Anne V. Philips(The University of Texas MD Anderson Cancer Center), Fei Yang(Roche (Switzerland)), Wafa Osmani(Dana-Farber Cancer Institute), Michael S. Goldberg(Jefferson Einstein Philadelphia Hospital), Wesley Lo(Dana-Farber Cancer Institute), Patrick Danaher(Nanostring Technologies (United States)), Jennifer L. Guerriero(Brigham and Women's Hospital), Jennifer Savoie(Dana-Farber Cancer Institute), Yun Wu, Katherine A. Hoadley(University of North Carolina at Chapel Hill), Jane Brock(Brigham and Women's Hospital), Adrienne Damicis(Ohio Department of Health)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k